bblagg	10.1016/j.juro.2011.02.1463	<http://dx.doi.org/10.1016/j.juro.2011.02.1463>; rel="canonical", <https://api.elsevier.com/content/article/PII:S0022534711017113?httpAccept=text/xml>; version="vor"; type="text/xml"; rel="item", <https://api.elsevier.com/content/article/PII:S0022534711017113?httpAccept=text/plain>; version="vor"; type="text/plain"; rel="item", <https://www.elsevier.com/tdm/userlicense/1.0/>; version="tdm"; rel="license"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.juro.2011.02.1463"><j.2:doi>10.1016/j.juro.2011.02.1463</j.2:doi><j.0:publisher>Ovid Technologies (Wolters Kluwer Health)</j.0:publisher><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/brian-blagg-1eri01h6p3z52"><j.3:name>Brian Blagg</j.3:name><j.3:familyName>Blagg</j.3:familyName><j.3:givenName>Brian</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="info:doi/10.1016/j.juro.2011.02.1463"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/george-vielhauer-1eri01h6p3z52"><j.3:name>George Vielhauer</j.3:name><j.3:familyName>Vielhauer</j.3:familyName><j.3:givenName>George</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/andrew-james-1eri01h6p3z52"><j.3:name>Andrew James</j.3:name><j.3:familyName>James</j.3:familyName><j.3:givenName>Andrew</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jeffrey-eskew-1eri01h6p3z52"><j.3:name>Jeffrey Eskew</j.3:name><j.3:familyName>Eskew</j.3:familyName><j.3:givenName>Jeffrey</j.3:givenName></j.3:Person></j.0:creator><j.2:volume>185</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/roger-rajewski-1eri01h6p3z52"><j.3:name>Roger Rajewski</j.3:name><j.3:familyName>Rajewski</j.3:familyName><j.3:givenName>Roger</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="doi:10.1016/j.juro.2011.02.1463"/><j.1:doi>10.1016/j.juro.2011.02.1463</j.1:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jeffrey-holzbeierlein-1eri01h6p3z52"><j.3:name>Jeffrey Holzbeierlein</j.3:name><j.3:familyName>Holzbeierlein</j.3:familyName><j.3:givenName>Jeffrey</j.3:givenName></j.3:Person></j.0:creator><j.0:title>610 IN VIVO EFFICACY OF KU-174, A C-TERMINAL INHIBITOR OF HSP90 IN A PC3 XENOGRAFT MODEL</j.0:title><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2011-04</j.0:date><j.1:volume>185</j.1:volume><j.0:identifier>10.1016/j.juro.2011.02.1463</j.0:identifier><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0022-5347"><j.1:issn>1527-3792</j.1:issn><j.2:issn>1527-3792</j.2:issn><owl:sameAs>urn:issn:1527-3792</owl:sameAs><owl:sameAs>urn:issn:0022-5347</owl:sameAs><j.0:title>Journal of Urology</j.0:title><j.1:issn>0022-5347</j.1:issn><j.2:issn>0022-5347</j.2:issn></j.2:Journal></j.0:isPartOf></rdf:Description></rdf:RDF>
